How high-density lipoprotein protects against the effects of lipid peroxidation

被引:157
作者
Mackness, MI [1 ]
Durrington, PN [1 ]
Mackness, B [1 ]
机构
[1] Univ Manchester, Manchester Royal Infirm, Dept Med, Manchester M13 9WL, Lancs, England
关键词
D O I
10.1097/00041433-200008000-00007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The protective effect of HDL against the development of atherosclerosis appears to be multifaceted involving a number of mechanisms. One of the major mechanisms is, however, the ability of HDL to decrease, directly or indirectly, the lipid peroxidation of LDL, The hydrolysis of lipid peroxides by PON1 makes a major contribution to this effect of HDL. Evidence is accumulating that the PON1 activity of human serum can be modulated by a variety of natural compounds and that these may increase or decrease the protective ability of PON1 and therefore of HDL on which it is exclusively located. Modulations of PON1 that enhance its activity may help to delay the atherosclerotic process. Curr Opin Lipidol 11:383-388. (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:383 / 388
页数:6
相关论文
共 64 条
  • [41] Biologically active oxidized phospholipids
    McIntyre, TM
    Zimmerman, GA
    Prescott, SM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (36) : 25189 - 25192
  • [42] MILLER GJ, 1975, LANCET, V1, P16
  • [43] Reaction of phosphatidylcholine hydroperoxide in human plasma: The role of peroxidase and lecithin:cholesterol acyltransferase
    Nagata, Y
    Yamamoto, Y
    Niki, E
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1996, 329 (01) : 24 - 30
  • [44] HIGH-DENSITY-LIPOPROTEIN INHIBITS THE OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN
    PARTHASARATHY, S
    BARNETT, J
    FONG, LG
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1044 (02) : 275 - 283
  • [45] Oxidized low-density lipoprotein, a two-faced Janus in coronary artery disease?
    Parthasarathy, S
    Santanam, N
    Augé, N
    [J]. BIOCHEMICAL PHARMACOLOGY, 1998, 56 (03) : 279 - 284
  • [46] Parthasarathy S, 1999, J LIPID RES, V40, P2143
  • [47] Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes
    Pfohl, M
    Koch, M
    Enderle, MD
    Kühn, R
    Füllhase, J
    Karsch, KR
    Häring, HU
    [J]. DIABETES, 1999, 48 (03) : 623 - 627
  • [48] Determination of paraoxonase (PON1) status requires more than genotyping
    Richter, RJ
    Furlong, CE
    [J]. PHARMACOGENETICS, 1999, 9 (06): : 745 - 753
  • [49] Polymorphism in high density lipoprotein paraoxonase gene and risk of acute myocardial infarction in men:: prospective nested case-control study
    Salonen, JT
    Malin, R
    Tuomainen, TP
    Nyyssönen, K
    Lakka, TA
    Lehtimäki, T
    [J]. BRITISH MEDICAL JOURNAL, 1999, 319 (7208) : 487 - 488
  • [50] GREATER SELECTIVE UPTAKE BY HEP G2 CELLS OF HIGH-DENSITY-LIPOPROTEIN CHOLESTERYL ESTER HYDROPEROXIDES THAN OF UNOXIDIZED CHOLESTERYL ESTERS
    SATTLER, W
    STOCKER, R
    [J]. BIOCHEMICAL JOURNAL, 1993, 294 : 771 - 778